International Approaches to Regulation of Medicinal Products Containing Viable Human Cells
The intensive development of cellular technologies stipulates the introduction at the global level of medicinal products based on viable human cells, which in most countries are referred to as biomedical cell products. The authors conducted a comparative analysis of the regulatory framework in diffe...
Main Authors: | E. V. Melnikova, A. A. Goryaev, M. V. Savkina, O. V. Merkulova, A. A. Chaplenko, O. A. Rachinskaya, I. S. Semenova, G. A. Trusov, V. A. Merkulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-09-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/170 |
Similar Items
-
Methodological aspects of the development of product files for biomedical cell products
by: E. V. Melnikova, et al.
Published: (2021-07-01) -
Regulation for the Translation of Gene and Cell Therapy into Medical Practice in East Asian Countries
by: E. V. Melnikova, et al.
Published: (2024-02-01) -
International Practice of Storing Human Cell Lines Intended for Clinical Use
by: O. A. Rachinskaya, et al.
Published: (2018-12-01) -
Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
by: E. V. Melnikova, et al.
Published: (2020-07-01) -
Current Trends in the Use of Cell Therapy in Regenerative Medicine
by: A. A. Chaplenko, et al.
Published: (2020-06-01)